Who Can Benefit from Therapeutic Plasma Exchange? Key Conditions Explained

Therapeutic Plasma Exchange (TPE) is a versatile therapy, but it is not for everyone. The American Society for Apheresis (ASFA) rigorously evaluates and categorizes diseases based on how well they respond to TPE.

Here is a guide to the key conditions where TPE is proven to be beneficial.

Category I: First-Line Therapy

For these conditions, TPE is a primary, standard-of-care treatment.

1. Guillain-Barré Syndrome (GBS): Acute paralysis following infection. TPE speeds recovery and reduces ventilator dependency.
2. Myasthenia Gravis (Crisis): Severe muscle weakness affecting breathing. TPE is life-saving.
3. CIDP (Chronic Inflammatory Demyelinating Polyneuropathy): Chronic nerve weakness. TPE improves grip strength and walking ability.
4. TTP (Thrombotic Thrombocytopenic Purpura): A blood clotting disorder. TPE is mandatory for survival.

Category II: Second-Line / Adjunct Therapy

TPE is used when other treatments fail or in combination with them.

1. Multiple Sclerosis (Acute Relapse): Used when high-dose steroids fail to improve symptoms of an attack.
2. Neuromyelitis Optica (NMO): Used for acute attacks affecting vision or the spinal cord.
3. Hashimoto’s Encephalopathy: A rare brain inflammation linked to thyroid antibodies. TPE often results in dramatic cognitive improvement.

Emerging Indications (Research Phase)

Conditions showing promise in trials but not yet standard of care.

1. Alzheimer’s Disease: The AMBAR trial showed significant slowing of decline in moderate patients.
2. Long COVID: Early research suggests TPE may help remove microclots and autoantibodies associated with Long COVID fatigue.
3. Lyme Disease: Some protocols use TPE to remove inflammatory complexes in chronic Lyme, though this is considered alternative.

Who is NOT a Candidate?

• Patients with active infections (sepsis).
• Patients with severe hemodynamic instability (uncontrolled heart/BP issues).
• Patients with no venous access.

Conclusion

If you have an antibody-mediated autoimmune disease or a neurodegenerative condition, consult your specialist. Checking the ASFA guidelines is the best way to determine if TPE is a recognized option for your specific diagnosis.